2020
DOI: 10.5530/ijper.54.4.176
|View full text |Cite
|
Sign up to set email alerts
|

Artificial Intelligence: A New Paradigm for Pharmaceutical Applications in Formulations Development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 6 publications
0
3
0
Order By: Relevance
“…AI is already widely used in healthcare, and the studies included in this analysis involved the use of AI in such aspects as disease screening, diagnosis, risk warning, adjuvant therapy and intelligent healthcare. In addition, AI is increasingly being applied in the research and development of new drugs,41 as well as in the prevention and treatment of COVID-19 42. With the accumulation of massive medical data and the improvement of hardware computing capacity, medical AI has built a data-driven deep learning system 43.…”
Section: Discussionmentioning
confidence: 99%
“…AI is already widely used in healthcare, and the studies included in this analysis involved the use of AI in such aspects as disease screening, diagnosis, risk warning, adjuvant therapy and intelligent healthcare. In addition, AI is increasingly being applied in the research and development of new drugs,41 as well as in the prevention and treatment of COVID-19 42. With the accumulation of massive medical data and the improvement of hardware computing capacity, medical AI has built a data-driven deep learning system 43.…”
Section: Discussionmentioning
confidence: 99%
“…Currently, the application of artificial intelligence technology in the healthcare supply chain is mainly reflected in the following five aspects. First, the application of artificial intelligence technology in pharmaceutical research and development ( 31 ), the significant changes in the field of pharmaceutical research and development are closely related to the breakthrough progress in the field of artificial intelligence ( 32 ). In the face of the extremely large pharmaceutical industry data, AI can be used to process the data through appropriate algorithmic models, and then used in the process of pharmaceutical R&D, which can effectively accelerate the speed of pharmaceutical product development, reduce the cost of R&D, and improve the success rate of research and development.…”
Section: Literature Reviewmentioning
confidence: 99%
“…Therefore these well-designed A.I. methods can greatly speed up the development process, enhance the product stability, as well as provide high expertise relationship between various formulation and process parameters (8). Hence A.I.…”
Section: Introductionmentioning
confidence: 99%